XML 21 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Statement of Cash Flows
7 Months Ended
Dec. 31, 2025
USD ($)
Cash Flows from Operating Activities:  
Net income $ 2,984,991
Adjustments to reconcile net income to net cash used in operating activities:  
Payment of operation costs through IPO Promissory Note 17,420
Interest earned on marketable securities held in Trust Account (3,235,039)
Changes in operating assets and liabilities:  
Prepaid expenses (11,920)
Prepaid insurance (118,664)
Accounts payable and accrued expenses 47,756
Net cash used in operating activities (315,456)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (275,000,000)
Net cash used in investing activities (275,000,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Public Units, net of underwriting discounts paid 270,200,000
Proceeds from sale of Private Placements Warrants 6,800,000
Repayment of IPO Promissory Note – related party (170,256)
Payment of offering costs (328,044)
Net cash provided by financing activities 276,501,700
Net Change in Cash 1,186,244
Cash – Beginning of period
Cash – End of period 1,186,244
Noncash investing and financing activities:  
Offering costs included in accrued offering costs 75,000
Deferred offering costs paid through IPO Promissory Note – related party 152,836
Deferred underwriting fee payable $ 11,700,000